Status: Recruiting
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
This is a phase 1 basket trial of TGFBR2 KO CAR27/IL-15 NK cells after lymphodepleting chemotherapy for patients with R/R B-NHL, HL, T-NHL or B-ALL.
Participants needed: 60
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Jun 26, 2026Locations: 1
Eligibility criteria
18-75 years of age. [+25]
Lymphoma or ALL in CR with no measurable sites of disease. [+15]